U.S., July 12 -- ClinicalTrials.gov registry received information related to the study (NCT07059793) titled 'MITRIS China Post Market Clinical Follow-up (PMCF) Study' on June 13.
Brief Summary: Collect clinical outcomes on acute and long-term safety and performance of the MITRIS RESILIA Mitral Valve, Model 11400M, in subjects requiring replacement of their native or prosthetic mitral valve with or without concomitant procedures.
Study Start Date: July, 2025
Study Type: OBSERVATIONAL
Condition:
Mitral Valve Replacement
Intervention:
DEVICE: MITRIS RESILIA Mitral Valve
Surgical replacement of native or prosthetic mitral valve.
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Edwards Lifesciences
Published by HT Digital Content Servi...